DNA/RNA

Description
The gene encompasses 9013 bp of DNA; 16 or 17 exons (the first and second are non-coding). 
Transcription
Expression
Widely expressed, especially in brain, heart, skeletal muscle and kidney.
Localisation
Cytosol.
Function
A candidate tumor suppressor gene. Ndrg2 expressed much higher in normal tissues than the tumors (brain, liver, pancreas tissues etc). Overexpression of ndrg2 can inhibit the proliferation of glioblastoma U373 and U138 cells. NDRG2 upregulation is associated with disease pathogenesis in the human brain. Ndrg2 is expressed during the differentiation of DCs, and the expression is differentially regulated by maturationinducing stimuli such as LPS and CD40. The expression of ndrg2 in rat frontal cortex was decreased by chronic antidepressant treatment.
Homology
At the amino acid level, human NDRG2 shows 57% identical to NDRG1 and NDRG3, 65% identical to NDRG4-B, 63% identical to NDRG4-Bvar and 61% identical to NDRG4-H respectively. Also human NDRG2 shows 92% identical to mouse NDRG2.
Implicated in
Alzheimer's disease Disease Alzheimer's disease is the most common cause of dementia. Dementia is a collective name for progressive degenerative brain syndromes, which affect memory, thinking, behavior and emotion. Symptoms NDRG2 (NDRG family member 2) Yao L et al. Atlas Genet Cytogenet Oncol Haematol. 2005; 9(4) may include: 1) lose of memory; 2) difficulty in finding the right words or understanding what people are saying; 3) difficulty in performing previously routine tasks; 4) personality and mood changes. Prognosis The probable outcome is poor. The disorder is usually not acute, but progresses steadily. Total disability is common. Death normally occurs within 15 years, usually from an infection or a failure of other body systems. The duration of illness, from onset of symptoms to death, averages 8 to 10 years. Hybrid/Mutated gene NDRG2 is upregulated at both the RNA and protein levels in AD brains. Expression of NDRG2 in affected brains was revealed in: (1) cortical pyramidal neurons, (2) senile plaques and (3) cellular processes of dystrophic neurons. NDRG2 upregulation is associated with disease pathogenesis in the human brain.
Liver cancers
Disease Liver cancers are primary liver tumors (hepatoma/hepatocellular carcinoma, bile duct cancer/cholangio-carcinoma) or metastatic liver tumor. Oncogenesis Compared with adjacent normal tissues, the expression levels of NDRG2 mRNA in liver cancer tissues reduced significantly, but the mutation in the whole coding region of NDRG2 was not found.
Glioblastoma
Disease Glioblastoma multiforme (GBM) is the most aggressive form of the primary brain tumors known collectively as gliomas. These tumors arise from the supporting, glial cells of the brain during childhood and in adults. These growths do not spread throughout the body like other forms of cancer, but cause symptoms by invading the brain.NDRG2 gene was first found in this tissue by using subtraction cloning. Oncogenesis Ndrg2 is present at low levels in human GBM tissues and glioblastoma cell lines comparing with normal tissue and cells. Transient transfection exogenous NDRG2 gene will inhibits glioblastoma U373 and U138 cells proliferation.
Gastric cancer
Disease
Gastric cancer is the result of cell changes in the lining of the stomach. The most common types of stomach cancer start in the glandular cells of the stomach lining and are known as adenocarcinomas. These are rare cancers that usually start from the cells of the muscle layer of the stomach. The most common type of sarcoma to affect the stomach is a leiomyosarcoma.
Another type of sarcoma is a gastrointestinal stromal tumour (GIST). Oncogenesis Ndrg2 is present at low level in some stomach cancer tissue and cell lines.
